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Bombyx mori nucleopolyhedrosis virus (BmNPV), a 
natural pathogen of great economic significance in 
sericulture, has been exploited to generate recombi-
nant baculoviruses harbouring genes of choice and 
achieve high level expression of cloned foreign genes. 
The BmNPV-based expression system offers the adv-
antage of using the larval host rather than the insect-
derived cell lines for economic large-scal  synthesis of 
biomolecules. Since commercial rearing of silkworms 
is routinely practised, a part of the silkworm stocks 
can be diverted to produce biomolecules other than 
silk and the more sophisticated tissue culture method-
ologies can be dispensed with on an industrial scale. 
Nonetheless, the BmNPV-based expression considera-
bly lags behind the AcMNPV system in vogue today, 
in terms of the choice of expr ssion-optimized cloning 
vectors and easy recombinant generation kits that are 
commercially available. This review provides a brief 
outline of the current state of knowledge on the basic 
biology and genomics of BmNPV and how the virus 
has been made use of to produce biomolecules 
through its larval host, the mulberry silkworm. Since 
hyper-transcription from the viral very late gene 
promoters forms the basis of high level expression 
through recombinant baculoviruses, some aspects 
of the viral gene transcription and the role of late 
gene expression factors have also been included in the 
review. 
 
BOMBYX mori nucleopolyhedrovirus (BmNPV, formerly 
known as Bombyx mori nuclear polyhedrosis virus), is a 
natural pathogen of the mulberry silkworm Bombyx mori, 
and is of great economic concern to the silk farmer. Since 
there are no specific preventive measures for the occur-
rence and spread of BmNPV infection other than sani-
tized breeding and rearing methods, he only commercial 
practice today is to discard large stocks of worms in case 
of infection. Although sensitive diagnostic kits for early 
detection of BmNPV have been developed, they are not 
extensively used on a commercial scale. Even if the infe-
ction is detected, in the absence of any remedial meas-
ures for the containment of virus infection, the only 
solution at present is to discard whole rearing trays 
containing thousands of larvae to avoid the spread of the 
disease. Early detection of virus infection, however, per-
mits early discards without going through prolonged rear-
ing procedures and the consequent higher economic loss. 
The multivoltine, native Indian races of B. mori (e.g. Pure 
Mysore and Nistari strains) in general, are more resistant 
to nucleopolyhedrovirus (NPV) infections compared to the 
exotic, high yielding bivoltine races. Although the genetic 
basis of susceptibility/resistance to viral infections in B. 
mori is not unequivocally established so far, engineering 
virus resistance to the more susceptible high yielders 
through genetic crossbreeding and possibly through trans-
genesis is of prime economic significance. 
 BmNPV belongs to the family of Baculoviridae, the 
largest and the most common among the seven families 
of viruses that infect arthropods. The baculoviruses have 
been used as biopesticides for insect control in early 
days, due to their narrow host range. Subsequently, the 
baculovirus based expression vector system (BEVS) has 
gained prominence for over-expression of cloned foreign 
genes in insect cells and larval caterpillars. Most eu-
karyotic proteins synthesized in insect cells are post-
translationally processed in a manner similar to the native 
proteins and are biologically active. The molecular biol-
ogy of baculoviruses1–3 and their use as expression vec-
tors4–7 have been extensively rviewed in the past. The 
protocols for manipulating baculoviruses for recombinant 
protein expression are also available as laboratory manu-
als8–12. The majority of information has been generated 
through Autographa californica multinucleocapsid nuc-
leopolyhedrovirus (AcMNPV), which is now considered 
as the prototype baculovirus. BmNPV is very closely 
related to AcMNPV and shares a significant level of  
homology at the genomic level.
Life cycle  
A characteristic feature of the NPV infection is the 
production of crystalline proteinaceous structures called 
occlusion bodies (OB) or polyhedra, in which several 
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virions are embedded and thus protected from nviron-
mental factors such as UV light, desiccation, proteases 
and nucleases. The two morphological subgroups within 
the NPVs are the single nucleocapsid NPV (Type spe-
cies: BmNPV) in which only one nucleocapsid is present 
per envelope, and the multinucleocapsid NPVs (Type 
species: AcMNPV) in which several (1–17) nucleocap-
sids are packaged per envelope. 
 Baculoviruses replicate in the nuclei of infected cells. 
The virus lifecycle is characterized by the production of 
two structurally and morphologically distinct types of 
virions, the occluded or polyhedra- erived virion (PDV) 
and the extracellular or budded virion (BV). The PDV is 
responsible for natural infection as the insect larvae  
ingest OBs along with food. The alkaline environment in 
the insect midgut dissolves the polyhedra and releases the 
virions. The liberated PDVs infect midgut epithelial cells 
by a receptor-mediated membrane fusion13. These infe-
cted cells produce the budded virions, which are also 
referred to as extracellular virus and are needed for lat-
eral propagation of infection within the larvae via haemo-
lymph and tracheae. The BVs infect many tissues in the 
larvae including fat bodies, ovaries and most endothelial 
cells14–16. Some tissues, however, escap  infection. For 
instance, BmNPV does not infect the silk glands of B. 
mori, which constitute a major component of the larval 
body17,18. The BVs enter the cell through receptor-
mediated endocytosis19,20. Following penetration of the 
plasma membrane, the nucleocapsid moves towards the 
cell nucleus by a process that requires actin-micro- 
filaments. At the nucleus, the viral nucleocapsid is 
uncoated and the DNA gets released. The nucleus be-
comes enlarged and a distinct electron dense granular 
structure, called virogenic stroma is formed. This struc-
ture gets associated with nuclear matrix and forms the 
site of nucleocapsid assembly. Viral transcription and 
replication take place in this region. A typical electron 
micrograph of BmN cells infected with BmNPV is pre-
sented in Figure 1. 
 Following virus replication, by about 12 h post-
infection (hpi), the progeny BVs are produced and  
released into the extracellular compartment. Soon after, 
mature PDVs (surrounded by an envelope) get packaged 
into occlusion bodies. Production of a large number of 
OBs results from the hyper-exp ession of polyhedrin 
(polh). The infected larvae continue to feed till large 
amounts of OBs accumulate. Eventually they stop feed-
ing and undergo several physiological changes. The cuti-
cle melanises, musculature becoms flaccid and the larva 
liquifies. Larval disintegration results in the releas of 
polyhedra into the environment and the subsequent 
spread of virus infection. 
 The occlusion bodies stabilize the virions by allowing 
them to remain viable for long periods in the environ-
ment. In addition to baculovir ses, insect viruses from 
both the Reoviridae (e.g. cytoplasmic polyhedrosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
viruses21) and the Poxviridae (e.g. entomopox viruses22) 
occlude their virions. Occlusion in these virus groups is 
also similar to that of baculoviruses in that the occlusion 
body protein gene is highly expressed and the occluded 
virions are released by the high pH encountered in the 
midgut of the susceptible insect. However, there exists no 
amino acid sequence or functional identity between any 
of the occlusion body proteins from these different virus 
families. 
 Baculovirus lifecycle in vitro, in the tissue culture sys-
tem, can be divided into three phases, viz. early, late and 
very late (see Box 1). The kinetics of the infection proc-
ess and the molecular events occurring during infection 
have been characterized extensively using AcMNPV and 
the host cell line, IPLB-Sf 21 derived from Spodop-
 
 
 
Figure 1. BmNPV infection of BmN cells. Transmission electron 
micrograph of BmN cells infected with BmNPV (60 h post infection), 
sectioned and viewed after staining with uranyl acetate and lead citrate 
is shown. The top panel shows the common features of a baculovirus 
infected cell. Occlusion bodies (OB) containing polyhedra-deriv  
virus (PDV) are present in the nuclei. Replication and assembly of viral 
nucleocapsids occur in the nucleus in association with the virogenic 
stroma (VS). The budded viruses (BV) are produc d in the nucleus and 
they bud out through plasma membrane. The PDV acquires an inner 
membrane before being packaged into OBs. The bottom panel shows 
the close up picture of BmNPV occlusion body. 
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Box 1. Baculovirus infection process 
 
Early phase*
(0–6 hpi) 
Late phase
(6–12 hpi)
Very late phase
(12–72 hpi)
Nucleocapsid assembly
*The timings are based on AcMNPV infection.The kinetics of BmNPV infection is a 
little slower; hpi, hours post infection; OBs, occlusion bodies.
Virus adsorption
Endocytosis
Nuclear entry
Nucleocapsid uncoating
Early gene transcription
Viral DNA replication
Late gene expression
Very late transcription
Occlusion body formation
Cell lysis and release of OBs
Budded virus particles
Virus occlusion bodies
 
 
tera frugiperda. BmNPV follows essentially the same 
pattern but the growth kinetics is a little slower. 
Genomic DNA sequence of BmNPV 
The complete nucleotide sequences of the baculoviruses 
AcMNPV, BmNPV, Orgyia pseudotsugata multinucleo-
capsid nucleopolyhedrovirus (OpMNPV), Lymantria dis-
par multinucleocapsid nucleopolyhedrovirus (LdMNPV) 
and Spodoptera exigua multinucleocapsid nucleopolyhe-
drovirus (SeMNPV) are currently available23–27. BmNPV 
shares a high degree of homology to AcMNPV genome 
whereas the OpMNPV and LdNPV genomic sequences 
differ markedly. The primary sequence of BmNPV has 
been analysed on the same lines as AcMNPV, to predict 
the potential protein-coding regions, gene organization, 
the sites for initiation of viral DNA replication and the 
presence of regulatory elements. The BmNPV genome is 
shorter by 5481 bp compared to the AcMNPV. The  
genomic organization of BmNPV is shown in Figure 2. 
 Most of the ORFs in BmNPV are present at compa- 
rable locations and share about 90% identity to the 
AcMPNV genome. The subtle changes in sequences, 
however, are responsible for the morphological and k-
netic differences between them, as well as the host speci-
ficity range. For instance, the species specificity of 
infection by AcMNPV has been attributed to the dna-
hel28,29. AcMNPV does not replicate in B. mori derived 
Bm5 or BmN cells, but when a short sequence within 
AcMNPV ORF95 (encoding viral DNA helicase, p143) is 
replaced with a collinear region of BmNPV, it acquires 
the ability to replicate in Bm cells or B. mori larvae. 
Amino acid changes at positions 564 (serine to aspar-
agine) and 577 (phenylalanine to leucine) were sufficient 
to extend the host range29. Recombination between 
AcMNPV and BmNPV could be achieved through coin-
fection of the viruses in the susceptible host cell line, to 
generate viruses with dual host range. 
 A notable feature of the genomic sequence is the pres-
ence of clustered EcoRI sites at five locations in the ge-
nome. These regions contain two to eight repeats of an 
imperfect palindrome with an EcoRI site at the centre of 
each palindrome. These regions being homologous to 
each other, are designated as homologous regions (hr). In 
AcMNPV there are nine such homologous regions, hr1, 
hr1a, hr2, hr2a, hr3, hr4a, hr4b, hr4c and hr5. They are 
200 to 1000 bp long and are located 15 to 55 kb apart in 
the 134 kb genome. Each repeating unit is usually 75 bp 
long with the EcoRI site at its core flanked by sequences, 
forming a 29 bp palindrome motif. The hr4 from 
AcMNPV is subdivided into left and right halves30. 
 The BmNPV genome also possesses seven hrs (hr1, 
hr2-left, hr2-right, hr3, hr4-left, hr4-right and hr5) found 
at positions similar to those in AcMNPV. The consensus 
sequence of the BmNPV hrs shows 95% homology to 
that in AcMNPV. Nucleotide sequence analysis of the 
BmNPV hr2, which is subdivided into left and right 
halves, suggests that it could have evolved from the an-
cesteral AcMNPV analogue by inversion, cleavage and 
ligation. The polarities of the BmNPV and AcMNPV hrs 
are conserved except for that of hr4-left31. The OpMNPV 
genome also harbours hr  but their locations are not 
comparable to the rs of AcMNPV or BmNPV. Bacu-
lovirus hrs are involved in viral gene expression and in 
replication32. Transient expression assays showed that the 
rs activate the baculovirus early genes 38K, ie-2 and 
p35 when placed either upstream or downstream to these 
genes. Similarily hr5 can activate gene expression from 
host promoters like actin 5C (ref. 33). This enhancement 
of gene expression is independent of viral infection but 
the virally encoded protein IE-1 stimulates the expression 
over 1000 fold. Hr1 has been reported to stimulate po h 
gene expression34. The hrs can also serve as origins of 
DNA replication35–37. 
 A few ORFs, such as ORF 603 in the polh locus and 
pcna from the lef8 region present in AcMNPV, are absent 
from BmNPV whereas some others like bro (baculovirus 
related ORFs) are repeated more frequently. The bros 
constitute a unique and highly conserved multigene fam-
ily, first reported from genome analysis of LdMNPV
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Figure 2. Genomic organization of BmNPV. BmNPV genome is a covalently closed circular DNA of 
128,413 bp. The restriction maps for the enzymes PstI and XhoI are shown (pink and grey, respectively) and the 
alphabets (capitals) mark the different fragments. The approximate locati ns of the seven hr sequences (hr1, 
hr2L, hr2R, hr3, hr4L, hr4R and hr5), which serve as potential origins of replication and/or enhancers for late 
gene expression, are marked in green. The late gene expression factors (lefs) involved in late gene transcription 
are marked in blue, and the polyhedrin and p10 genes which are mostly extensively exploited for high level  
expression of recombinant proteins are marked in red. All other markers are designated as the ORF numbers with 
a prefix of Bm (e.g. Bm4, Bm5) or based on their counterparts from AcMNPV (e.g. gp64, vp80). The 5 bro genes 
(baculovirus related ORFs) are also marked in purple. This circular map has been constructed based on the infor-
mation in ref. 24. For other details of the genomic markers and functions, see ref. 24. 
 
(which had 16 copies) homologous to the single copy 
ORF2 in AcMNPV. There are 5 copies of br  in BmNPV 
and 3 in OpMNPV. They are generally present as con-
tiguous clusters. The Ac-bro (ORF2), Bm-bro d and Ld-
bro n are the most highly conserved ones (82% identity 
in amino acid sequence) and many have similar functions 
in the infection cycle. All the 5 Bm-bro genes (bro a, b, c, 
d and e) are expressed as delayed early genes, and bro-d 
and e are located adjacent to each other in a head to tail 
arrangement38. BmNPV mutants lacking bro a, b, c, and e 
were viable whereas a null m tant of a bro d (equivalent 
of the single copy Ac-bro) was non-viable. It is specu-
lated that both bro a and c products may function as 
DNA-binding proteins that influence DNA replication 
and/or trancription39. The BmNPV transregulator IE-1 
was required for the activation of bro c promoter40. 
 Although nearly 135 genes (ORFs) are present in  
BmNPV, so far only a limited number has been charac- 
terized (listed in Table 1)41–58. However, most of the  
functions have been deduced based on the AcMNPV 
counterparts. The viral very late genes, both polh and p10 
whose strong promoters have been mostly exploited for 
recombinant protein expression, have been studied in 
some detail41–43. A striking difference is that the BmNPV 
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p10 encodes a 7.5 kDa protein due to the presence of a 
nonsense mutation arising from the deletion of an ‘A’ 
residue at the 3¢ region44. 
Gene expression patterns 
Gene expression pattern following baculovirus infection  
is regulated in a cascade fashion, where the activation of  
each set of genes relies on the synthesis of proteins from  
previous class. Based on this temporal regulation, the  
baculovirus genes are grouped into three classes: early,  
late and very late. Although most baculovirus genes can  
be placed into one of the above classes, some are tran- 
scribed in more than one phase. The early genes are tran- 
scribed prior to viral DNA replication and are subdivided  
into immediate early and delayed early class, whereas the  
late and very late genes are activated during or after viral  
DNA replication. The late genes are maximally active  
between 12 and 24hpi. The very late genes are hyper-
expressed following activation of late genes and remain  
active well after late gene expr ssion has diminished. The  
early genes generally encode proteins of regulatory func- 
tions, transcription, replication, and modification of host  
 
 
Table 1. Genes characterized from BmNPV 
Gene Function Reference 
 
polh Major viral occlusion body protein 41 
p10 Viral occlusion body protein forming  42 
 fibrillar structures  43, 44 
p39 Structural polypeptide 45 
cg30 Putative transcriptional regulator, 45 
   (harbours a RING finger like motif, 
  a leucine zipper and an acidic domain) 
p35 Anti-apoptotic protein 46 
p40 Virion-specific occlusion polypeptide  47 
lef-3 ss-DNA binding and helix destabilizing 48 
  activity  
p143/dnahel Host range determining factor 28 
dnapol DNA polymerase  49 
lef-8 Virus replication i  vivo and in vitro 50 
lef-2 Virus replication and late gene expression  51 
hr5 Non-essential for virus replication 31 
hr3 Transcriptional enhancer 33 
bro-a, b, c, d, e DNA-binding proteins 39 
dbp ss-DNA-binding protein and colocalizes 52 
 with IE-1 and LEF-3 in viral replication  53 
  machinery 
fp25 Causes few polyhedra phenotype and 54 
  implicated in post-mortem host degradation 
p95 Transcriptional regulator (harbours 2 Zn 55 
  finger motifs and a proline-rich region) 
ie-1 Transactivator protein essential for initiation56 
 of viral DNA replication, transcription from 39 
   bro c promoter 
v-cath Encodes a cysteine proteinase involved in 57 
  aborting host protein synthesis machinery,  
  horizontal transmission of infection 
p6.9 Basic DNA binding protein 58 
processes. Late proteins include those involved in regula-
tion of late and very late gene expression and the viral  
structural proteins. Very late proteins are those involved 
in the processes of occlusion and cell lysis. 
 Early genes are transcribed by the host RNA poly-
merase II. Many early promoters contain a functional 
TATA box59 typical of most RNA polymerase II promot-
ers of higher eukaryotes. Immediate early gene promoters 
are accurately transcribed by nuclear extracts prepared 
from uninfected host cells60. In addition to the TATA 
box, many baculovirus early promoters contain a con-
s rved sequence CAGT, at or near the transcription start 
site61–63. However, there are exceptions. For instance, the 
transcription of DNA pol from both BmNPV and 
AcMNPV initiates from a G/C rich sequence (5¢-GCG- 
TGCT-3¢ and 5¢-AGAGCGT-3¢) with no apparent TATA 
box in the vicinity49. Likewise, the AcMNPV lef4 tran-
script initiates from a G/C rich sequence and the Ac-iap 
transcript initiates from the sequence GAGTTGT. In add-
ition to the basal promoter elements, many enhancer  
el ments have also been identified in early promoters. 
 The early genes are subdivided into two groups, imme-
dia e early (ie) and delayed early (de). The former ones 
are fully active in the absence of viral factors whereas the 
de promoter requires one or more IE proteins for full act-
ivation. Most of the IE proteins are involved in the regu-
lation of viral transcription. The deletion of ie-2 from 
BmNPV reduces viral DNA replication by 2 fold in BmN 
cells64. 
 Virus infection is known to trigger the host cell death 
programme, apoptosis. AcMNPV however, evades this 
by encoding an inhibitor of apoptosis, p35, which is an 
inhibitor for a family of host cysteine proteases65. The 
BmNPV homologue of p35, with 90% identity (at the 
amino acid level) to the AcMNPV counterpart has been 
identified46. However, the two proteins seem to differ in 
their apoptotic activity66. 
 Late and very late transcription is dependent on early 
viral gene expression and viral DNA replication67,68. The 
late and very late promoters are unusual with respect to 
their structure and location. They differ from most RNA 
polymerase II promoters and do not contain DNA ele-
ments such as TATA box. The primary determinant for 
the late and very late promoter activity is the pentanu-
cleotide A/G/TTAAG, which is located at the transcrip-
tion start point of all known late and very late genes2,69. 
Late and very late promoters are distinguished by their 
relative activities during late and very late phases. The 
promoters of polh and p10 belonging to the very late 
class, exhibit low activity during the late phase (6–
18 hpi) but become highly active at 18hpi. By 24 to 
48 hpi approximately 20% of the total polyadenylated 
RNA in the cell is polh mRNA. The polh promoter is 
relatively well conserved between distantly related bacu-
loviruses2 and is marked by the presence of a 12nt con-
sensus sequence spanning the transcription star  site 
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(A/T)(A/G) TAAGNA(T/A/C)(T/A)T. This consensus is 
also present in the very late p10 gene promoters. 
 The polh promoter of AcMNPV has been characterized 
most extensively by deletion69 and linker-scan mutational 
analyses70,71. The transcription initiation site is within the 
highly conserved sequence TAAATAAGTATT. The 
minimal essential polh promoter has been d fined as a 
69 bp stretch (–1 to –69 nt with respect to +1 ATG) to 
confer hyper expression at very late periods. The TAAG 
portion of this sequence is absolutely essential for tran-
scription initiation to occur because linker scan substitu-
tions affecting the TAAG site decreased rporter gene 
expression approximately 2000-fold and lowered the 
steady state levels of RNA to undetectable levels. Se-
quences in the leader region between TAAG and the start 
codon also have a strong influence on polhtranscription. 
Sequential deletion in the polh leader sequence upstream 
from the ATG adversely affects the reporter gene expres-
sion72. In polh 5¢ upstream sequences of BmNPV also, 
transcription enhacer elements that stimulate expression 
from polh promoter are present73. 
 Sequences proximal to the polh start codon (up to 
+ 35 nt) substantially increase the level of expression of 
foreign genes in recombinant baculovirus vectors in 
AcMNPV, possibly by increasing the stability of 
mRNA5. In BmNPV, the sequence till + 5 nt from the 
first ATG of polyhedrin was sufficient to direct maximal 
expression of cloned foreign genes74. 
 The virus-encoded genes responsible for mediating the 
late gene transcription have been identified in a transient 
expression system utilizing a mixture of successively 
smaller fragments of the baculovirus genome that are 
able to activate the late and very late promoters75,76. 
Nineteen late gene expression factors (lefs) have been 
identified to be necessary and sufficient to mediate late 
gen expression from late and very late promoters. These 
genes could have directly activated late/very late gene 
transcription or exerted indirect effect by stimulating 
early gene transcription or through mediating DNA repli-
cation. Nine of these (ie-1, ie-2, lef-1, lef-2, lef-3, lef-7, 
p143, dnapol and p35) are involved in hr2-based DNA 
replication whereas the products of the other nine genes 
(lef-4, lef-5, lef-6, lef-8, lef-9, lef-10, lef-11, 39k and p47) 
affect the steady state levels of reporter gene transcripts 
and are thus likely to be involved in some aspects of 
transc iption, transcript processing or stability68. More 
recently, however, a complex of l f-4, lef-8, lef-9 and p47 
encoded proteins from AcMNPV has been shown to ini-
tiate transcription from p lh promoter in vitro77. 
 Most of the lefs have been identified only by transient 
expression studies and their individual functions are not 
yet delineated. The available information on the function 
of lefs has been summarized in Table 2. The role of lefs 
in virus multiplication and late gene expression in vivo in 
BmNPV has been investigated by deleting each lef homo-
logue from the genome64. Of the 19 lefs, deletion mutants 
could be isolated only for 4 (39k, ie-2, lef-7 and p35). 
Deletion mutants for the other 15 could not be generated 
probably because they are essential for virus multiplica-
tion. The lef2 from BmNPV encodes a 23 kDa, dual func-
tio  protein, which plays a role in both viral DNA 
replication and late gene expression51. The function in 
 
 
Table 2. Late gene expression factors from BmNPV@ 
 ORF   Size Identity*  Homology/ 
Gene (bp)   (kDa) aa (%) Promoter motifs Function 
 
lef-2  630 23.6 96 E/L Cys-rich Replication/transcription 
lef-1  810 31.0 96 E/L Primase Replication 
lef-6  519 20.2 93 –   – LEF 
39k  831 31.3 92 E/L Basic, DNA binding LEF, Phosphoprotein (ne) 
lef-11  336 13.0 97 e   – LEF 
p47 1197 47.1 98 e/E   – DNA binding, LEF 
lef-8 2631 101.6 98 – RNApolb¢ Transcription 
lef-10  417 16.7 96 L   – LEF 
lef-9 1470 56.2 98 – RNApolb¢ Transcription  
dnapol 2958 114.3 96 e/E DNA pol Replication 
lef-3 1155 44.7 92 E SSB Replication 
vlf-1 1137 44.2 98 L Integrase Very late expression 
lef-4 1395 53.8 97 E Acidic domain Transcription 
dnahel 3666 143.5 96 E Helicase Replication, host specificity 
lef-5  795 31.0 97 –   – LEF 
lef-7  636 24.9 88 E SSB, UL 29(HSV) Replication (ne) 
p35  897 34.8 91 E/L   – Block apoptosis (ne) 
ie-1 1752 66.8 96 E   – Transactivator 
ie-2 1266 48.7 73 E/L Zinc finger Transactivator (ne) 
E, early; L, late; e, enhancer in the near upstream region; ne, nonessential. 
LEF, Late gene expression factor protein encoded by lef g nes 
(@ modified from ref. 64; *identity to AcMNPV counterparts). 
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late gene expression is possibly as a transcriptional coac-
tivator (Sriram and Gopinathan, unpublished observa-
tions). 
 A viral gene for the ‘burst’ of very late gene transcrip-
tion, very late gene expression factor-1 (vlf-1) has also 
been identified in AcMNPV and a mutation in the gene 
results in significant reduction in polh and p10 mRNA 
levels78. The vlf-1 encoded protein shows considerable 
homology to the lambda phage integrase family and the 
mutation in any of the conserved amino acid residues 
adversely affects the virus production79. A counterpart 
for vlf-1 is present in BmNPV also.  
 A comparative analysis of gene expr ssion patterns in 
BmN cells following BmNPV infection has been carried 
out recently80. The profiling of expressed sequence tags 
generated at different times following virus infection 
confirmed the predicted patterns. For instance, ie-0 and 
ie-2 transcripts could be detected in 2 h, whereas the 
transcripts of several genes associated with viral DNA 
replication and the lefs as well as structural genes like 
gp64 were detected by 6 h. Interestingly, in this c-DNA 
approach, the expression profiling of several host genes, 
ranging from complete suppression to enhanced synthesis 
consequent to virus infection, could also be established.  
BmNPV-based high level expression of cloned 
foreign genes 
Baculovirus-based expression systems using recombinant 
insect viruses in insect cell lines have become the method 
of choice in recent years for generating biomolecules in 
large amounts for basic biological studies and biomedical 
purposes. Although over 500 baculoviruses are known, 
AcMNPV has been most thoroughly developed, followed 
by BmNPV for expressing foreign genes. More than a 
thousand genes, ranging from the components of basal 
transcription machinery such as TBP and transcrip ion 
factors to viral coat and envelop proteins (e.g. HIV major 
surface glycoprotein, GP120 and envelope protein, 
GP41) have been cloned and expressed through recombi-
nant AcMNPV and BmNPV. Baculovirus-based expres-
sion in insect cells provides an environment that is 
conducive to proper folding, disulfide bond formation, 
oligomerization and other post-tran lational modifica-
tions of the synthesized protein, all of which are essential 
to achieve biological activity.  
 Two desirable features of baculoviruses account for 
their success as expression vectors. First, the virus con-
tains a number of nonessetial genes that can be replaced 
by a foreign gene. Second, many viral genes, particularly 
the very late ones are under the control of strong promot-
ers that allow abundant expression of the passenger 
recombinant gene. For high level expression of recombi-
nant protein, most frequently the two very late genes, 
polh and p10, which are hyper-transcribed and nonessen-
tial for virus multiplication, are replaced by the foreign 
gene. This allelic replacement is achieved by homologous 
recombination between the wild type virus and a transfer 
ve tor harbouring the foreign gene. However, the bacu-
lovirus genome is too large to permit routine manipula-
tions for insertion of foreign genes. Therefore, the 
generation of recombinant virus is achieved as a two-step 
process: (i) the construction of recombinant transfer vec-
tor harbouring the foreign gene of interest and (ii) the 
pro ction of recombinant baculovirus by cotransfection 
of insect cells with wild-type viral DNA and the transfer 
vector. 
 The transfer vector is a bacterial plasmid carrying a 
portion of the baculovirus genome spanning  strong 
promoter to be used for foreign gene expression (e.g. 
polh, p10) and its 5¢ upstream region as well as the 
downstream region flanking the termination sequences in 
order to facilitate recombination with the viral DNA. 
Transcriptional enhancer elements that stimulate expres-
sion from the polh promoter are also present in the 5¢ 
flanking region73. A suitable, multiple cloning site (MCS) 
is located immediately downstream to the promoter so 
that the expression of the inserted foreign gene at the 
MCS is controlled by the viral promoter. The minimum 
lengths of the upstream and downstream sequences 
needed for optimal recombination are not yet fully char-
acterized. The first generation transfer vectors were very 
large (more than 10 kb in size), and therefore, were lim-
ited in their capacity to accommodate large foreign genes 
or multiple genes as inserts. More recently the size of the 
vectors has been reduced to accommodate large or multi-
ple foreign genes. 
 Both polh and p10 promoters from AcMNPV are rec-
ognized efficiently as the homologous promoters in 
BmNPV-infected BmN cells17. The expression from p10
promoter ranges from 20 to 60% of that from the p lh 
promoter. The levels of expression from polh promoter, 
in general, are dependent on the position at which the 
recombinant gene is located. Thus, in BmNPV-infected 
BmN cells, the expression of the reporter gene from 
BmNPV polh promoter when located at –3 nt with  
respect to the + 1 ATG was only 10–20% of the xpres-
sion levels from the heterologous AcMNPV polh pro-
moter in which the gene was located at + 35 nt 
(Sehrawat and Gopinathan, unpublished results). Many 
transfer plasmids for multiple gene expression and for 
expression under alternate promoters are currently avail-
able for AcMNPV. The presence of purification tags (e.g. 
glutathione-S-transferase fusion or affinity His tag) and 
secretory signals at the cloning site are important new 
additions to BEV technology. 
Traditionally, recombination between the transfer plas-
mid and viral genomic DNA is carried out in insect 
host cells following transfection. The plasmid and viral 
DNAs are cotransfected by calcium phosphate-medi t d 
DNA uptake or lipofection. Alternately, the insect cells are 
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transfected with the plasmid DNA and followed by viral 
infection. After 48–72 h of transfection/infection, viral 
progenies are screened for recombinants wherein a segment 
of the viral genome is replaced by the region harboured in 
the transfer vector plasmid. The recombinant viruses are 
isolated by several rounds of plaque purification. 
 The type of selection method used for isolating recom-
binant virus depends upon the parental virus used, the 
gene being replaced in the virus and the selection marker 
available in the transfer vector. If the foreign gene is 
inserted at polh locus, the recombinant virus will demon-
strate an occ- phenotype and the screening procedures 
depend on the tedious selection for occ- plaques. Typi-
cally, only 0.1– % of the progeny viruses are recombi-
nants. Hence, a large number of plaques need to be 
screened. However, many improvements have occurred 
in achieving recombination and plaque selection in the 
last few years, mostly in the AcMNPV system. If lin-
earized viral DNA is used in the cotransfection step 
instead of the native viral DNA (which is circular), the 
proportion of recombinant viruses in the progeny in-
creases to about 25% (ref. 81). A modification of this 
approach82 involves the removal of a portion of the ge-
nome encompassing parts of an essential virus gene 
(ORF 1629, located downstream of polh), by restriction 
enzymes. Under these conditions more than 85–95% effi-
ciency recombinant virus generation is achieved. Direct 
ligation of foreign gene into baculovirus vectors is an-
other attractive way for generating ecombinant viruses83. 
Modified AcMNPV DNA, with a multiple cloning 
site composed of unique restriction sites (e.g. B u361, 
Sse83871 and SrfI) has been engineered to facilitate  
direct ligation of EcoRI, PstI and blunt-ended DNA frag-
ments84. 
 The other modifications of baculovirus recombinant 
selection involve the use of yeast and bacterial cells 
where the entire baculovirus genome is maintained. The 
AcMNPV genome has been reconstituted as a replicon to 
propagate in the yeast, S. cerevisiae by inserting a yeast 
autonomously replicating sequence (ARS) at the polh 
locus together with a centromere sequence to ensure sta-
ble low copy number segregation of the viral genome and 
serve as a suitable selection marker85. This allows easier 
manipulation of the viral genome in yeast and more 
straightforward selection procedures. Similarly the 
AcMNPV genome has also been reconstituted as a repli-
con in E. coli86, by inserting the origin of replication 
from the mini-F replicon at the viral polh locus along 
with kanr and lacZ as selection markers. This baculoviral 
DNA, which multiplies in both insect cells and bacteria, 
is called ‘bacmid’. The insertion of foreign gene is 
achieved by a site-sp cific recombination mediated by 
Tn10 transposon at the lacZ locus. The transposase en-
zyme is encoded by a helper plasmid. The recombinant 
bacmid, thus can be selected by a simple blue-white se-
lection in E. coli. The recombinant baculoviral DNA iso-
lated from the bacterial host is directly transfected into 
the insect cells to generate the recombinant virus with a 
high proportion (almost 100%) of recombinants. 
 Making use of the above principles, several high effi-
ciency recombinant generation kits are commercially 
available for AcMNPV-based expression and they 
are marketed under various commercial names such as 
‘Baculogold’, ‘Bacpac’, ‘Bac-to-Bac’, etc. These kits 
provide simple and direct selection for recombinant 
plaque selection and purification in a week’s time, but 
ost of these technologies are restricted to the AcMNPV 
system. The BmNPV-based expression system mainly 
relies on the tedious occ– plaque selection methods. 
However, the successful use of recombinant BmNPV 
harbouring luc or gfp as a parent for recombinant genera-
tion has somewhat simplified the recombinant selection 
that can be achieved through scoring for loss of lumine-
scence or gfp fluorescence17,18. 
 Th  cell lines supporting AcMNPV replication (Sf9, 
Sf21 and TN386) are superior in growth characteristics 
and expression levels to cell lines supporting BmNPV 
replication (BmN and Bm5). Besides, the range of trans-
fer plasmid vectors and parent viruses available for the 
AcMNPV-based expression system is much more than 
that of BmNPV system. Moreover, a variety of late and 
very late promoters with protein purification tags (GST, 
His) and secretory signals, as well as methodologies for 
rapid recombinant selection, are available for the 
AcMNPV-based system. Nonetheless, the BmNPV-based 
expression system offers the advant ge of economically 
viable, over-production of recombinant proteins in insect 
l rvae rather than in cell cultures. The larval host of 
BmNPV, the silkworm Bombyx mori is 10 times larger 
than the larval hosts of AcMNPV and can be readily 
reared in the laboratory on mulberry leaves or a synthetic 
diet. Therefore, once the recombinant virus is generated 
in cell culture, the larval caterpillar can be exploited for 
the pr duction of the recombinant protein in lieu of cell 
cultures. Thus, the use of a BmNPV-based larval expres-
sion offers an attractive, more economic protein produc-
tion sy em, particularly for proteins that are secreted in 
the hemolymph.  
The exploitation of BmNPV and the use of B. mori 
larvae for the first time, for the production of recombi-
nant interferon was reported about 16 years ago87. Subse-
quently our own group here has improved the 
transfection efficiency of BmN cells by employing 
lipofection, which facilitated the recombinant genera-
t on88. Very high levels of expression of luciferase 
through recombinant BmNPV in the larval caterpillar 
(10 mg recombinant protein per larva) were achieved, 
which resulted in the generation of ‘Glowing silkworms’ 
emanating significant luminescence on administration of 
the substrate luciferin (Figure 3 a). We have also demon-
strated that the larval expression succesfully handles 
multiple intron splicing, albeit with limited efficiency89. 
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Figure 3. Expression of recombinant proteins in B. mori larvae. a, Silkworm larvae expressing high levels of 
luciferase on infection with recombinant BmNPV harbouring firefly luciferase gene, emanates significant 
amounts of luminescence on administration of the substrate luciferin. b, B mori larvae infected with recombinant 
BmNPV harbouring the gfp gene under the polh promoter expressing green fluorescent protein (larvae on the 
right). Control larvae infected with wild type BmNPV is shown on the left. c a d d, BmN cells in culture and the 
trachea from B. mori larvae infected with recombinant BmNPV harbouring gfp showing high levels of expression 
of the green flourescent protein. e, Expression of recombinant antigen ORF3 from Hepatitis E virus. Western blot 
of the fat body proteins from recombinant BmNPV infected B. mori larvae using the polycl nal antibodies to 
ORF3, showing the single band of Hepatitis E-ORF3. 
 
The complex eukaryotic gene hGH, encoding the human 
growth hormone harbours 4 introns and 5 exons. Thi  
gene transcript was properly spliced and the translated 
product was secreted into the insect circulation system. 
The hGH from the haemolymph could be readily purified 
in a single-step immunoaffinity chromatography and the 
insect-synthesized protein was indistinguishable from the 
authentic hGH in both radioimmunoassay and radiore- 
ceptor assay89. However, the expression levels of hGH 
were much lower (100– 5  mg per larva) compared to 
luciferase. 
 Subsequently, we have shown that the polh and p10 
promoter constructs from AcMNPV system can be suc-
cessfully utilized to generate BmNPV recombinants 
through homologous recombination17,18. These results 
established that the wide variety of AcMNPV-based 
transfer vectors currently available can be utilized for 
generating BmNPV recombinants, despite the fact that 
polh promoter flanking sequences are not identical in 
these viruses. The generation of the recombinant BmNPV 
harbouring the green fluorescent protein g e (gfp) has 
opened up the possibility of using this tagged virus for 
pathological investigations on BmNPV infection in B. 
mori larvae, as it leaves the footprints of gfp expression 
(see Figure 3 b–d). The larvally expressed GFP, though a 
nonsecretory protein, could be readily isolated from 
the larval fat bodies. However, since the B. mori larvae 
have an open circulatory system and the fat bodi s s 
well as most other tissues lie immersed in the haemo-
lymph, substantial quantities of even non-secretory pro-
teins leach out into the haemolymph. Therefore, the 
recovery of the larvally expressed recombinant proteins, 
even when they are nonsecretory in nature, can be readily 
achieved. 
 Our group has also expressed a viral antigen desig-
nated ORF3 from Hepatitis E virus. However, the expres-
sion levels in cell lines or larvae were very low and the 
expressed viral antigen could be detected only in Western 
blots (Figure 3 e). The reason for the very low levels of 
expression is not clear but the codon bias and codon us-
age patterns could be the main contributing factor. 
 A comprehensive but not necessarily comp ete list of 
the proteins expressed so far through recombinant 
BmNPV and B. mori derived cell lines or larvae is pro-
vided in Table 3. 
 Since the polh locus is mostly utilized for the insertion 
of foreign genes, the recombinant virus generated will 
have a polh– phenotype and the occlusion bodies are not 
formed at the culmination of infection. This ensures a 
built-in containment from inadvertent infection of other 
insect larvae because the non-occluded viruses do not 
survive long in the environment, and nor are they infec-
e 
a b 
c d 
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tive to the larvae by the oral route. These nonoccluded 
viruses have to be injected into the haemolymph to initi-
ate the infection. Therefore, biosafety is built into the 
system. 
 A double recombinant BmNPV harbouring two foreign 
genes at polh and p10 loci would provide the advantage 
of simultaneous expression of proteins, which may be 
desirable at times. 
Conclusions 
It is evident that while considerable information is avail-
able on the molecular biology and applic tion of 
AcMNPV as an expression system, the parallel system of 
BmNPV has lagged behind. The lack of availability of 
simplified recombinant selection procedures and a vast 
collection of optimized transfer vectors, as well as the 
‘more demanding’ behaviour of the B. mori derived cell 
lines in culture, have been the major deterrents. However, 
the demonstration that heterologous AcMNPV-based 
vectors can be used to generate BmNPV recombinants 
has circumvented at least one of the problems. Further, 
the use of silkworm larvae, rather than B. mori derived 
cell lines for the high level expression of foreign proteins 
(once the recombinant virus is generated), confers a dis-
tinct advantage to the BmNPV system. Since commercial 
rearing of silkworms for the production of silk is widely 
practised and is inexpensive compared to the tissue cul-
ture methodologies, a small proportion of the silkworm 
rearing stocks may be channelled to produce, ‘high 
value’, ‘low volume’ biological products, utilizing the 
silkworm as a natural bioreactor. This technology offers 
tremendous economic potential to ‘sericulture countries’ 
like India. 
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